Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.
Phase II trial report of preoperative chemotherapy (CX) with S-1 plus cisplatin for stage IV gastric cancer (StIV GC). Background: The prognosis varied among the patients with the same stage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results